|
Post by marykudro on Jul 21, 2021 7:21:04 GMT -5
The proteasome inhibitor bortezomib, alone and along with, is highly effective in Multiple Myeloma, producing high RR and resulting in improved OS across disease settings. The bortezomib price is usually reasonable at every GDP & ISO certified pharmaceutical wholesaler/pharmacy. Bortezomib is used as a 3 to 5 second IV push. It may be injected directly into the peripheral line, central line catheter, or an infusion port followed by standard saline flush to ensure administration of the full dose. The drug bortezomib is administered twice a week for 2 weeks followed by a 10-day rest period at 1.3 mg/m2 dose in a 21-day cycle regimen.
|
|